1-3 of 3
Sebastian Balleisen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reapplication of High-Dose Chemotherapy and Autologous Blood Stem Cell Transplantation as Salvage Treatment for Patients with Relapsed or Refractory Multiple Myeloma – a Single Center Experience.

Roland Fenk, MD, PhD, Vanessa Liese, Ingmar Bruns, MD, PhD, Mustafa Kondakci, MD, Sebastian Balleisen, MD, Christian Saure, Thomas Schröder, MD, Rainer Haas, MD, Prof, Guido Kobbe, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3418.
https://doi.org/10.1182/blood.V114.22.3418.3418
Published: 2009
Journal Articles

Escalation Treatment Algorithm with Bortezomib, Dexamethasone and Bendamustine for Patients with Relapsed or Refractory Multiple Myeloma: A Singel Centre Experience.

Roland Fenk, MD, Mark Michael, Fabian Zohren, Thorsten Graef, MD, Arkosch Czibere, MD, Sebastian Balleisen, MD, Frank Neumann, MD, Ulrich-Peter Rohr, MD, Ulrich Steidl, MD, Rainer Haas, MD, Guido Kobbe, MD
Journal: Blood
Blood (2006) 108 (11): 3540.
https://doi.org/10.1182/blood.V108.11.3540.3540
Published: 2006
Journal Articles

Cytogenetic Remission Status after Induction Chemotherapy for AML and High-Risk MDS Predicts Long-Term Outcome.

Sebastian Balleisen, MD, Hildebrand Barbara, PhD, Royer-Prokora Brigitte, PhD, Kuendgen Andrea, MD, Gattermann Norbert, MD, Germing Ulrich, MD, Haas Rainer, MD
Journal: Blood
Blood (2004) 104 (11): 3009.
https://doi.org/10.1182/blood.V104.11.3009.3009
Published: 2004